Pediatric HIV/AIDS Cohort Study (PHACS) 2020
儿科艾滋病毒/艾滋病队列研究 (PHACS) 2020
基本信息
- 批准号:10465786
- 负责人:
- 金额:$ 45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-18 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:13 year oldAddressAdolescentAdolescent and Young AdultAdultAgeAgingAnti-Retroviral AgentsBrainBrain regionCaringCenters for Disease Control and Prevention (U.S.)Cervical Intraepithelial NeoplasiaChildChild HealthCognitiveCohort StudiesCommunitiesData AnalysesDevelopmentDiseaseDisease remissionEffectivenessEpidemiologic MethodsEpidemiologyExposure toGrantGrowthGuidelinesHIVHIV InfectionsHPV-High RiskHealthHealth behaviorHealth educationHuman PapillomavirusHuman papilloma virus infectionIndividualInfantInfant HealthInfectionInfrastructureLife Cycle StagesLong-Term EffectsMonitorNatural HistoryNeurologicOral healthOutcomePediatric HIV/AIDS Cohort StudyPerinatalPersonsPharmaceutical PreparationsPopulationPregnant WomenPrevalencePreventionProgram Research Project GrantsProspective cohort studyProtocols documentationResearch Project GrantsRiskRisk FactorsSafetySeriesSiteStatistical MethodsTestingToxic effectVaccinatedYouthadverse birth outcomesbehavioral outcomecardiometabolismclinical research sitecohortdata managementdata resourcedesignemotion regulationemotional behaviorexperiencein uteromultidisciplinaryneurodevelopmentoral HPVperinatal HIVpostnatalprogramsreproductivesocial structuresuccesssurveillance studytransmission processtreatment responseyoung adultyoung manyoung woman
项目摘要
Project Summary/Abstract
Each year, there are more than 1 million pregnant women living with HIV (PWLHIV) who receive antiretroviral
medications (ARVs) for treatment and perinatal and postnatal HIV transmission prevention, with new ARVs
introduced at a rapid pace. Although maternal use of ARVs has successfully reduced perinatal HIV
transmission, there remains a clear need to monitor the safety of in utero ARV for infant and child health.
Currently, 1.7 million children under the age of 15 are living with HIV globally – the vast majority with perinatally
acquired HIV infection (PHIV) - who are aging into young adulthood. In the US, the Centers for Disease Control
and Prevention (CDC) estimates that in 2016, there were 11,915 persons with PHIV in the U.S, including 1,814
children younger than 13 years of age and 10,101 adolescents and young adults. The lifelong impact of HIV
and ARVs on their overall health is unknown as they transition into adulthood and adult HIV care.
The Pediatric HIV/AIDS Cohort Study (PHACS) is a network, initiated in 2007, currently consisting of two
prospective cohort studies: The Surveillance Monitoring for ART Toxicities Study (SMARTT), with over
4,000 infants, children and youth with perinatal HIV exposure but who are uninfected (PHEU), and the series of
Adolescent Master Protocols (AMP, AMP Up and AMP Up Lite) studies following 1,000 young adults with
perinatal HIV, and a comparison cohort of young adults with PHEU. These studies are designed to answer
questions regarding the short and long term outcomes of HIV infection and ARV exposure or treatment.
PHACS 2020 is designed as a Program Project P01 grant, consisting of the following four support Cores:
Scientific Administrative Core (SAC), Data Resources Core (DRC), Health Education and Community Core
(HECC), and the Epidemiological and Statistical Methods Core (ESC) to provide scientific, site and cohort
infrastructure, data management and analysis, health education and community input, as well as
epidemiological and statistical support to four Research Projects: 1) SMARTT; 2) The Adolescent Master
Protocol (AMP) Up Series (the AMP Up Series); 3) Natural History of Cervical Intraepithelial Neoplasia
(CIN) and Human Papillomavirus (HPV) in HPV Vaccinated Youth with PHIV (HPV); and the TERBO
BRAIN Study: Trajectories of Emotional Regulation and Behavior Outcomes and related Brain Regions
And Intrinsic Networks (TERBO BRAIN). This multidisciplinary, interdisciplinary, transdisciplinary and
synergistic P01 will address the most critical scientific questions for children, youth and young adults exposed
to or living with HIV.
项目总结/摘要
每年有100多万感染艾滋病毒的孕妇接受抗逆转录病毒治疗
用于治疗和预防围产期及产后艾滋病毒传播的抗逆转录病毒药物,以及新的抗逆转录病毒药物
以快速的速度推出。虽然母亲使用抗逆转录病毒药物成功地减少了围产期艾滋病毒感染,
尽管抗逆转录病毒药物在子宫内传播的风险很小,但仍明显需要监测子宫内抗逆转录病毒药物对婴幼儿健康的安全性。
目前,全球有170万15岁以下的儿童感染艾滋病毒,其中绝大多数是围产期感染。
获得性艾滋病毒感染(PHIV)-他们正在进入青年期。在美国,疾病控制中心
美国疾病控制和预防中心(CDC)估计,2016年,美国有11,915人患有PHIV,其中包括1,814人
13岁以下的儿童和10 101名青少年和年轻人。艾滋病毒的终生影响
和抗逆转录病毒药物对他们的整体健康的影响是未知的,因为他们过渡到成年和成人艾滋病毒护理。
儿科艾滋病毒/艾滋病队列研究(PHACS)是一个网络,于2007年启动,目前由两个
前瞻性队列研究:ART毒性监测研究(SMARTT),
4,000名婴儿、儿童和青年在围产期接触艾滋病毒但未受感染(PHEU),
青少年主方案(AMP、AMP Up和AMP Up Lite)研究,随访1,000名患有
围产期艾滋病毒,并与PHEU的年轻成年人的比较队列。这些研究旨在回答
关于艾滋病毒感染和抗逆转录病毒药物暴露或治疗的短期和长期结果的问题。
PHACS 2020被设计为计划项目P01赠款,由以下四个支持核心组成:
科学管理核心(SAC),数据资源核心(DRC),健康教育和社区核心
(HECC)和流行病学和统计方法核心(ESC),以提供科学、研究中心和队列
基础设施、数据管理和分析、健康教育和社区投入,以及
为四个研究项目提供流行病学和统计支助:1)SMARTT; 2)青少年硕士
方案(AMP)UP系列(AMP UP系列); 3)宫颈上皮内瘤变的自然史
(CIN)和人乳头瘤病毒(HPV)在接种HPV疫苗的青年人中的作用;以及TERBO
脑研究:情绪调节和行为结果的轨迹及相关脑区
和内在网络(TERBO BRAIN)。这种多学科、跨学科、跨学科和
协同P01将解决儿童、青年和年轻人接触的最关键的科学问题。
艾滋病病毒感染者或携带者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ellen Gould Chadwick其他文献
Pyoderma gangrenosum in pediatric acquired immunodeficiency syndrome
- DOI:
10.1016/s0022-3476(05)82444-8 - 发表时间:
1990-07-01 - 期刊:
- 影响因子:
- 作者:
Amy S. Paller;Eleanor E. Sahn;Paul D. Garen;Richard L. Dobson;Ellen Gould Chadwick - 通讯作者:
Ellen Gould Chadwick
Influenza Vaccination in HIV-Infected Children: Serologic Response, Viral Load Changes and Effect of Vitamin A Supplementation ♦ 844
人类免疫缺陷病毒感染儿童的流感疫苗接种:血清学反应、病毒载量变化及维生素 A 补充的效果♦844
- DOI:
10.1203/00006450-199804001-00865 - 发表时间:
1998-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Willem A Hanekom;Lynn M Heald;Greg D Hussey;Ram Yogev;Kathryn M Edwards;Ellen Gould Chadwick - 通讯作者:
Ellen Gould Chadwick
Ellen Gould Chadwick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ellen Gould Chadwick', 18)}}的其他基金
Pediatric HIV/AIDS Cohort Study (PHACS) 2020
儿科艾滋病毒/艾滋病队列研究 (PHACS) 2020
- 批准号:
10290224 - 财政年份:2021
- 资助金额:
$ 45万 - 项目类别:
Pediatric HIV/AIDS Cohort Study (PHACS) 2020
儿科艾滋病毒/艾滋病队列研究 (PHACS) 2020
- 批准号:
10663894 - 财政年份:2020
- 资助金额:
$ 45万 - 项目类别:
Health Outcomes around Pregnancy and Exposure to HIV/ARV (HOPE): Extending the Reach of PHACS to Examine Women's Health
围绕怀孕和接触 HIV/ARV 的健康结果 (HOPE):扩大 PHACS 的范围以检查女性健康
- 批准号:
10249082 - 财政年份:2020
- 资助金额:
$ 45万 - 项目类别:
Pediatric HIV/AIDS Cohort Study (PHACS) 2020
儿科艾滋病毒/艾滋病队列研究 (PHACS) 2020
- 批准号:
10391037 - 财政年份:2020
- 资助金额:
$ 45万 - 项目类别:
Health Outcomes around Pregnancy and Exposure to HIV/ARV (HOPE): Extending the Reach of PHACS to Examine Women's Health
围绕怀孕和接触 HIV/ARV 的健康结果 (HOPE):扩大 PHACS 的范围以检查女性健康
- 批准号:
10437910 - 财政年份:2020
- 资助金额:
$ 45万 - 项目类别:
Pediatric HIV/AIDS Cohort Study (PHACS) 2020
儿科艾滋病毒/艾滋病队列研究 (PHACS) 2020
- 批准号:
10065440 - 财政年份:2020
- 资助金额:
$ 45万 - 项目类别:
Pediatric HIV/AIDS Cohort Study (PHACS) 2020
儿科艾滋病毒/艾滋病队列研究 (PHACS) 2020
- 批准号:
10264949 - 财政年份:2020
- 资助金额:
$ 45万 - 项目类别:
相似海外基金
Enhancing Structural Competency in School-Based Health Centers to Address LGBTQ+ Adolescent Health Equity
增强校本健康中心的结构能力,以解决 LGBTQ 青少年健康公平问题
- 批准号:
10608426 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别:
Application and feasability of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care - a pilot study
简短的数字筛查工具的应用和可行性,以解决儿科医疗中父母和青少年烟草和电子烟的使用问题 - 一项试点研究
- 批准号:
486580 - 财政年份:2022
- 资助金额:
$ 45万 - 项目类别:
Studentship Programs
Co-design of an intervention to address alcohol use among adolescent boys and young men in Tanzania
共同设计一项干预措施,解决坦桑尼亚青春期男孩和年轻男性的饮酒问题
- 批准号:
MR/V032380/1 - 财政年份:2022
- 资助金额:
$ 45万 - 项目类别:
Research Grant
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/1 - 财政年份:2021
- 资助金额:
$ 45万 - 项目类别:
Research Grant
Application of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care
应用简短的数字筛查工具来解决儿科医疗中父母和青少年烟草和电子烟的使用问题
- 批准号:
455984 - 财政年份:2021
- 资助金额:
$ 45万 - 项目类别:
Operating Grants
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/2 - 财政年份:2021
- 资助金额:
$ 45万 - 项目类别:
Research Grant
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10057761 - 财政年份:2020
- 资助金额:
$ 45万 - 项目类别:
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10213683 - 财政年份:2020
- 资助金额:
$ 45万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 45万 - 项目类别:
Designing targeted interventions to address HIV vulnerabilities and improve clinical outcomes among conflict affected adolescent girls and young women under 25 in Northern Uganda
设计有针对性的干预措施,以解决乌干达北部受冲突影响的少女和 25 岁以下年轻妇女的艾滋病毒脆弱性并改善临床结果
- 批准号:
356145 - 财政年份:2016
- 资助金额:
$ 45万 - 项目类别:
Operating Grants